Clinical but Not Histological Outcomes in Males with 45,X/46,XY Mosaicism Vary Depending on Reason for Diagnosis

Marie Lindhardt Ljubicic*, Anne Jørgensen, Carlo Acerini, Juliana Andrade, Antonio Balsamo, Silvano Bertelloni, Martine Cools, Rieko Tadokoro Cuccaro, Feyza Darendeliler, Christa E. Flück, Romina P. Grinspon, Andrea MacIel-Guerra, Tulay Guran, Sabine E. Hannema, Angela K. Lucas-Herald, Olaf Hiort, Paul Martin Holterhus, Corina Lichiardopol, Leendert H.J. Looijenga, Rita OrtolanoStefan Riedl, S. Faisal Ahmed, Anders Juul

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Context: Larger studies on outcomes in males with 45,X/46,XY mosaicism are rare. Objective: To compare health outcomes in males with 45,X/46,XY diagnosed as a result of either genital abnormalities at birth or nongenital reasons later in life. Design: A retrospective, multicenter study. Setting: Sixteen tertiary centers. Patients or Other Participants: Sixty-three males older than 13 years with 45,X/46,XY mosaicism. Main Outcome Measures: Health outcomes, such as genital phenotype, gonadal function, growth, comorbidities, fertility, and gonadal histology, including risk of neoplasia. Results: Thirty-five patients were in the genital group and 28 in the nongenital. Eighty percent of all patients experienced spontaneous pubertal onset, significantly more in the nongenital group (P = 0.023). Patients were significantly shorter in the genital group with median adult heights of 156.7 cm and 164.5 cm, respectively (P = 0.016). Twenty-seven percent of patients received recombinant human GH. Forty-four patients had gonadal histology evaluated. Germ cells were detected in 42%. Neoplasia in situ was found in five patients. Twenty-five percent had focal spermatogenesis, and another 25.0% had arrested spermatogenesis. Fourteen out of 17 (82%) with semen analyses were azoospermic; three had motile sperm. Conclusion: Patients diagnosed as a result of genital abnormalities have poorer health outcomes than those diagnosed as a result of nongenital reasons. Most patients, however, have relatively good endocrine gonadal function, but most are also short statured. Patients have a risk of gonadal neoplasia, and most are azoospermic, but almost one-half of patients has germ cells present histologically and up to one-quarter has focal spermatogenesis, providing hope for fertility treatment options.

Original languageEnglish
Pages (from-to)4366-4381
Number of pages16
JournalJournal of Clinical Endocrinology and Metabolism
Volume104
Issue number10
DOIs
Publication statusPublished - 1 Oct 2019

Cite this